Dr Kitty van Weezenbeek (MD, PhD, MPH), Director Surveillance, Prevention and Control of antimicrobial resistance (SPC), WHO Geneva
Kitty leads the WHO AMR/SPC Department which primarily focuses on human health aspects of AMR, such as infection prevention and control; laboratory strengthening and diagnostic stewardship; and surveillance of AMR and antimicrobial use. In addition, the SPC Department supports countries with the development, costing and implementation of One Health National Action Plans, and evidence generation for innovation of AMR control.
Before joining WHO in May 2020, Kitty was Executive Director of KNCV Tuberculosis Foundation. She worked twice before with WHO, first as Task Manager drug-resistant TB in Geneva and later as regional advisor TB and leprosy control in the Western Pacific Region, based in Manila. During the last 25 years she focused on surveillance, prevention and control of MDR/XDR-TB; served on WHO TB Strategic Technical Advisory Group (STAG) and numerous WHO guideline committees; and chaired several global MDR-TB committees. Since 1984, she has assisted over 35 countries worldwide. Kitty is a medical doctor, with an MPH and a PhD on drug-resistant tuberculosis.
Date: June 21, 2021
Time: 9:15 – 10:45 am